Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijayalakshmi Mahadevan

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Drug Discovery Today|September 26, 2017
Targeting the cancer epigenome: synergistic therapy with bromodomain inhibitorsMahalakshmi Ramadoss, Vijayalakshmi Mahadevan
Current Neuropharmacology|October 22, 2015
Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regenerationShabir Ahmad Ganai, Mahalakshmi Ramadoss, Vijayalakshmi Mahadevan
Apoptosis : an International Journal on Programmed Cell Death|October 30, 2013
DAPK and cytoskeleton-associated functionsJelena Ivanovska, Vijayalakshmi Mahadevan, Regine Schneider-Stock
Translational Oncology|August 27, 2025
Histone Deacetylase Inhibitors orchestrate epigenetic signalling and alter the nucleoporins and nuclear envelope in cervical cancerHarsha Rani, Shabir Ahmad Ganai, Vijayalakshmi Mahadevan
Journal of Biomolecular Structure & Dynamics|March 8, 2017
HDAC inhibitors show differential epigenetic regulation and cell survival strategies on p53 mutant colon cancer cellsMahalakshmi R, Husayn Ahmed P, Vijayalakshmi Mahadevan
Journal of Biomolecular Structure & Dynamics|January 28, 2014
Energy-optimised pharmacophore approach to identify potential hotspots during inhibition of Class II HDAC isoformsShabir Ahmad Ganai, Karthi Shanmugam, Vijayalakshmi Mahadevan
Journal of Biomolecular Structure & Dynamics|July 12, 2014
HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cellsShabir Ahmad Ganai, Shashwath Malli Kalladi, Vijayalakshmi Mahadevan
Epigenetics & Chromatin|December 13, 2025
Gain of function p53 mutant R273H confers distinct methylation profiles and consequent YAP/TAZ signaling mediated activation of partial or full EMT states to colon tumoursHarsha Rani, Seemadri Subhadarshini, Mohit Kumar Jolly, et al.
Mutagenesis|December 5, 2019
The activating transcription factor 2: an influencer of cancer progressionKerstin Huebner, Jan Procházka, Ana C Monteiro, et al.
Journal of Biomolecular Structure & Dynamics|March 18, 2016
In silico and In vitro evaluation of the anti-inflammatory potential of Centratherum punctatum Cass-AKrithika S Shankaran, Shabir Ahmad Ganai, Arun K P, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Drug Discovery Today|September 26, 2017
Targeting the cancer epigenome: synergistic therapy with bromodomain inhibitorsMahalakshmi Ramadoss, Vijayalakshmi Mahadevan
Current Neuropharmacology|October 22, 2015
Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regenerationShabir Ahmad Ganai, Mahalakshmi Ramadoss, Vijayalakshmi Mahadevan
Apoptosis : an International Journal on Programmed Cell Death|October 30, 2013
DAPK and cytoskeleton-associated functionsJelena Ivanovska, Vijayalakshmi Mahadevan, Regine Schneider-Stock
Translational Oncology|August 27, 2025
Histone Deacetylase Inhibitors orchestrate epigenetic signalling and alter the nucleoporins and nuclear envelope in cervical cancerHarsha Rani, Shabir Ahmad Ganai, Vijayalakshmi Mahadevan
Journal of Biomolecular Structure & Dynamics|March 8, 2017
HDAC inhibitors show differential epigenetic regulation and cell survival strategies on p53 mutant colon cancer cellsMahalakshmi R, Husayn Ahmed P, Vijayalakshmi Mahadevan
Journal of Biomolecular Structure & Dynamics|January 28, 2014
Energy-optimised pharmacophore approach to identify potential hotspots during inhibition of Class II HDAC isoformsShabir Ahmad Ganai, Karthi Shanmugam, Vijayalakshmi Mahadevan
Journal of Biomolecular Structure & Dynamics|July 12, 2014
HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cellsShabir Ahmad Ganai, Shashwath Malli Kalladi, Vijayalakshmi Mahadevan
Epigenetics & Chromatin|December 13, 2025
Gain of function p53 mutant R273H confers distinct methylation profiles and consequent YAP/TAZ signaling mediated activation of partial or full EMT states to colon tumoursHarsha Rani, Seemadri Subhadarshini, Mohit Kumar Jolly, et al.
Mutagenesis|December 5, 2019
The activating transcription factor 2: an influencer of cancer progressionKerstin Huebner, Jan Procházka, Ana C Monteiro, et al.
Journal of Biomolecular Structure & Dynamics|March 18, 2016
In silico and In vitro evaluation of the anti-inflammatory potential of Centratherum punctatum Cass-AKrithika S Shankaran, Shabir Ahmad Ganai, Arun K P, et al.
Pageof 3